<DOC>
	<DOCNO>NCT00352287</DOCNO>
	<brief_summary>The purpose study determine effect growth hormone insulin sensitizer drug pre-diabetic adult excessive amount abdominal fat . Participants receive combination two drug : ( 1 ) recombinant human growth hormone ( placebo ) ( 2 ) pioglitazone ( placebo ) . We measure abdominal fat content blood sugar level participant 40 week treatment .</brief_summary>
	<brief_title>Study Determine Effects Human Growth Hormone Pioglitazone Overweight , Prediabetic Adults</brief_title>
	<detailed_description>Treatment recombinant human growth hormone ( GH ) show reduce visceral adipose tissue ( VAT ) improve insulin sensitivity normoglycemic adult , glucose level may rise transiently . Pioglitazone , thiazolidinedione ( TZD ) drug , counter short-term diabetogenic effect GH rodent , combine use drug evaluate human . The purpose study determine effect GH TZD , alone combination , glucose metabolism , visceral adiposity insulin sensitivity abdominally obese adult impair glucose tolerance . The hypothesis combine treatment attenuate GH-induced increase glucose concentration , reduces VAT , improve insulin sensitivity time test . Sixty-two adult receive GH pioglitazone 40 week double-blind , randomize , placebo-controlled trial .</detailed_description>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Age 40 75 year BMI &gt; 27 kg/m2 Waist circumference &gt; 100 cm men &gt; 88 cm woman Impaired glucose tolerance ( documented 75 gram OGTT ) Diabetes mellitus Malignancy Premenopausal woman breastfeed decline contraception Congestive heart failure ALT &gt; 3 time upper normal limit</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Visceral fat</keyword>
	<keyword>Impaired glucose tolerance</keyword>
	<keyword>Insulin resistance</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>Thiazolidinedione</keyword>
</DOC>